Download PDF
Endoscopy 2010; 42(7): 546-556
DOI: 10.1055/s-0029-1244127
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE)

C.  Stock1 , 2 , H.  Brenner1
  • 1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • 2Network Aging Research (NAR), University of Heidelberg, Heidelberg, Germany
Further Information

Publication History

submitted 10 September 2009

accepted after revision 15 March 2010

Publication Date:
29 April 2010 (online)

Also available at
    Permissions and Reprints

Background and study aims: Lower gastrointestinal endoscopy (sigmoidoscopy and colonoscopy) and the fecal occult blood test (FOBT) are thought to impact on colorectal cancer incidence and mortality. We aimed to estimate prevalences and to investigate potential determinants of utilization of these procedures in the general population across Europe.

Methods: Data from the Survey of Health, Aging, and Retirement in Europe (SHARE) were used. Prevalences of lower gastrointestinal endoscopy and FOBT utilization among adults aged ≥ 50 years in 11 countries (Austria, Belgium, Denmark, France, Germany, Greece, Italy, The Netherlands, Spain, Sweden, and Switzerland) were estimated. Potential determinants of utilization of the tests were analyzed by multivariate logistic regression.

Results: Overall, 18 139 individuals were included. The proportion of respondents reporting lower gastrointestinal endoscopy and FOBT utilization within the previous 10 years ranged from 6.1 % (95 % confidence interval [CI] 4.7 – 6.9; Greece) to 25.1 % (95 %CI 22.1 – 27.2; France) and from 4.1 % (95 %CI 3.2 – 4.9; The Netherlands) to 61.1 % (95 %CI 58.6 – 63.6; Austria), respectively. Observed sex differences were highest in France and Germany; however results were only partly statistically significant. Country, age, education, income, marital status (FOBT only), location of main residence (FOBT only), smoking history, and self-perceived health status were statistically significant predictors of test utilization.

Conclusion: Prevalences of lower gastrointestinal endoscopy and FOBT utilization vary widely across European countries. They need to be considered in the interpretation of cross-national differences and time trends in colorectal cancer incidence and mortality, and in the design and evaluation of colorectal cancer screening programs.

References

  • 1 Parkin D M, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002.  CA Cancer J Clin. 2005;  55 74-108
    Google Scholar
  • 2 Ferlay J, Autier P, Boniol M. et al . Estimates of the cancer incidence and mortality in Europe in 2006.  Ann Oncol. 2007;  18 581-592
    CrossrefPubMedGoogle Scholar
  • 3 Hewitson P, Glasziou P, Irwig L. et al . Screening for colorectal cancer using the faecal occult blood test, Hemoccult.  Cochrane Database Syst Rev. 2007;  CD001216
    PubMedGoogle Scholar
  • 4 Newcomb P A, Norfleet R G, Storer B E. et al . Screening sigmoidoscopy and colorectal cancer mortality.  J Natl Cancer Inst. 1992;  84 1572-1575
    CrossrefPubMedGoogle Scholar
  • 5 Müller A D, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans.  Arch Intern Med. 1995;  155 1741-1748
    CrossrefPubMedGoogle Scholar
  • 6 Baxter N N, Goldwasser M, Paszat L. et al . The effectiveness of colonoscopy in reducing mortality from colorectal cancer.  Ann Intern Med. 2009;  150 1-8
    CrossrefPubMedGoogle Scholar
  • 7 Kahi C J, Imperiale T F, Juliar B E, Rex D K. Effect of screening colonoscopy on colorectal cancer incidence and mortality.  Clin Gastroenterol Hepatol. 2009;  7 770-775
    CrossrefPubMedGoogle Scholar
  • 8 Arditi C, Peytremann-Bridevaux I, Burnand B. et al . Appropriateness of colonoscopy in Europe (EPAGE II) – screening for colorectal cancer.  Endoscopy. 2009;  41 200-208
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Levin B, Lieberman D A, McFarland B. et al . Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.  Gastroenterology. 2008;  134 1570-1595
    CrossrefPubMedGoogle Scholar
  • 10 U.S. Preventive Services Task Force . Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement.  Ann Intern Med. 2008;  149 627-637
    PubMedGoogle Scholar
  • 11 Sung J JY, Lau J Y, Young G P. et al . Asia Pacific consensus recommendations for colorectal cancer screening.  Gut. 2008;  57 1166-1176
    CrossrefPubMedGoogle Scholar
  • 12 De Laet C, Neyt M, Vinck I. Health Technology Assessment, et al .Colorectale Kankerscreening: wetenschappelijke stand van zaken en budgetimpact voor België. In: KCE reports. Brussels; Federaal Kenniscentrum voor de gezondheidszorg (KCE) 2006
    PubMedGoogle Scholar
  • 13 Benson V S, Patnick J, Davies A K. et al . Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.  Int J Cancer. 2008;  122 1357-1367
    CrossrefPubMedGoogle Scholar
  • 14 Classen M, Lambert R. Colorectal cancer screening in Europe: a survey of the international digestive cancer alliance between November 2004 and March 2007.  Z Gastroenterol. 2008;  46 23-24
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Gutierrez-Ibarluzea I, Asua J, Latorre K. Policies of screening for colorectal cancer in European countries.  Int J Technol Assess Health Care. 2008;  24 270-276
    PubMedGoogle Scholar
  • 16 West N, Boustière C, Fischbach W. et al . Colorectal cancer screening in Europe: differences in approach; similar barriers to overcome.  Int J Colorectal Dis. 2009;  24 731-740
    CrossrefPubMedGoogle Scholar
  • 17 Stock C, Haug U, Brenner H. Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends.  Gastrointest Endosc. 2010;  71 366-381
    CrossrefPubMedGoogle Scholar
  • 18 Klimont J, Kytir J, Leitner B. Austrian Health Survey 2006/2007 [Österreichische Gesundheitsbefragung 2006/2007 – Hauptergebnisse und methodische Dokumentation]. Vienna, Austria; Bundesministerium für Gesundheit, Familie und Jugend/Statistik Austria 2007
    PubMedGoogle Scholar
  • 19 Haidinger G, Waldhoer T, Vutuc C. Self-reported colonoscopy screening in Austria.  Eur J Cancer Prev. 2008;  17 354-357
    CrossrefPubMedGoogle Scholar
  • 20 Hoffmeister M, Chang-Claude J, Brenner H. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk.  Am J Epidemiol. 2007;  166 130-136
    CrossrefPubMedGoogle Scholar
  • 21 Sieverding M, Matterne U, Ciccarello L. Gender differences in FOBT use: evidence from a large German survey.  Z Gastroenterol. 2008;  46 (suppl 1) S47-51
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Wuppermann D, Wuppermann U, Riemann J F. Aktueller Wissensstand der Bevölkerung zur Darmkrebsvorsorge – eine Untersuchung der Stiftung LebensBlicke mit dem Institut für Demoskopie in Allensbach [Actual state of knowledge of the German population about the early detection of colorectal cancer – a study by ”the Stiftung LebensBlicke” in Cooperation with the Institute for Demoscopy in Allensbach].  Z Gastroenterol. 2009;  47 1132-1136
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Kamposioras K, Mauri D, Golfinopoulos V. et al . Colorectal cancer screening coverage in Greece. PACMeR 02.01 study collaboration.  Int J Colorectal Dis. 2007;  22 475-481
    CrossrefPubMedGoogle Scholar
  • 24 Börsch-Supan A, Hank K, Jürges H. A new comprehensive and international view on ageing: introducing the ’Survey of Health, Ageing and Retirement in Europe’.  Eur J Ageing. 2005;  2 245-253
    CrossrefPubMedGoogle Scholar
  • 25 Börsch-Supan A, Jürges H, eds The Survey of Health, Aging, and Retirement in Europe – Methodology. Mannheim, Germany; Mannheim Research Institute for the Economics of Aging (MEA) 2005 Available at http://www.share-project.org/ [Accessed: 25 January 2010]
    Google Scholar
  • 26 Börsch-Supan A, Brugiavini A, Jürges H et al., eds Health, Ageing and Retirement in Europe. First results from the Survey of Health, Ageing and Retirement in Europe. Mannheim, Germany; Mannheim Research Institute for the Economics of Aging (MEA) 2005 Available at: http://www.share-project.org/ [Accessed: 25 January 2010]
    Google Scholar
  • 27 Börsch-Supan A, Kemperman M. The SHARE development process. In: Börsch-Supan A, Jürges H, eds The Survey of Health, Aging, and Retirement in Europe – Methodology. Mannheim, Germany; Mannheim Research Institute for the Economics of Aging (MEA) 2005
    PubMedGoogle Scholar
  • 28 Brugiavini A, Croda E, Paccagnella O. et al .Generated income variables in SHARE release 1. In: Börsch-Supan A, Jürges H, eds The Survey of Health, Aging, and Retirement in Europe – Methodology. Mannheim, Germany; Mannheim Research Institute for the Economics of Aging (MEA) 2005
    PubMedGoogle Scholar
  • 29 Breen N, Wagener D K, Brown M. et al . Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys.  J Natl Cancer Inst. 2001;  93 1704-1713
    CrossrefPubMedGoogle Scholar
  • 30 Subramanian S, Amonkar M M, Hunt T L. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey.  Cancer Epidemiol Biomarkers Prev. 2005;  14 409-416
    CrossrefPubMedGoogle Scholar
  • 31 Ata A, Elzey J D, Insaf T Z. et al . Colorectal cancer prevention: adherence patterns and correlates of tests done for screening purposes within United States populations.  Cancer Detect Prev. 2006;  30 134-143
    CrossrefPubMedGoogle Scholar
  • 32 Meissner H I, Breen N, Klabunde C N, Vernon S W. Patterns of colorectal cancer screening uptake among men and women in the United States.  Cancer Epidemiol Biomarkers Prev. 2006;  15 389-394
    CrossrefPubMedGoogle Scholar
  • 33 McQueen A, Vernon S W, Meissner H I. et al . Are there gender differences in colorectal cancer test use prevalence and correlates?.  Cancer Epidemiol Biomarkers Prev. 2006;  15 782-791
    CrossrefPubMedGoogle Scholar
  • 34 Centers for Disease Control and Prevention (CDC) . Use of colorectal cancer tests – United States, 2002, 2004, and 2006.  MMWR – Morb Mortal Wkly Rep. 2008;  57 253-258
    PubMedGoogle Scholar
  • 35 Shapiro J A, Seeff L C, Thompson T D. et al . Colorectal cancer test use from the 2005 National Health Interview Survey.  Cancer Epidemiol Biomarkers Prev. 2008;  17 1623-1630
    CrossrefPubMedGoogle Scholar
  • 36 Beydoun H, Beydoun M. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States.  Cancer Causes Control. 2008;  19 339-359
    CrossrefPubMedGoogle Scholar
  • 37 Cokkinides V E, Chao A, Smith R A. et al . Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older.  Prev Med. 2003;  36 85-91
    CrossrefPubMedGoogle Scholar
  • 38 Pollack L A, Blackman D K, Wilson K M. et al . Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations.  Prev Chronic Dis. 2006;  3 A50
    PubMedGoogle Scholar
  • 39 Ioannou G N, Chapko M K, Dominitz J A. Predictors of colorectal cancer screening participation in the United States.  Am J Gastroenterol. 2003;  98 2082-2091
    CrossrefPubMedGoogle Scholar
  • 40 Thompson B, Coronado G, Neuhouser M, Chen L. Colorectal carcinoma screening among Hispanics and non-Hispanic whites in a rural setting.  Cancer. 2005;  103 2491-2498
    CrossrefPubMedGoogle Scholar
  • 41 Honda K. Factors associated with colorectal cancer screening among the US urban Japanese population.  Am J Public Health. 2004;  94 815-822
    CrossrefPubMedGoogle Scholar
  • 42 Kahi C J, Rex D K, Imperiale T F. Screening, surveillance, and primary prevention for colorectal cancer: a review of the recent literature.  Gastroenterology. 2008;  135 380-399
    CrossrefPubMedGoogle Scholar
  • 43 Carlos R C, Underwood 3rd  W, Fendrick A M, Bernstein S J. Behavioral associations between prostate and colon cancer screening.  J Am Coll Surg. 2005;  200 216-223
    CrossrefPubMedGoogle Scholar
  • 44 Pox C, Schmiegel W, Classen M. Current status of screening colonoscopy in Europe and in the United States.  Endoscopy. 2007;  39 168-173
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 International Cancer Screening Network (ICSN) .Inventory of colorectal cancer screening activities in ICSN countries, May 2008. http://appliedresearch.cancer.gov/icsn/colorectal/screening.html [Accessed: 15 June 2009]
    PubMedGoogle Scholar
  • 46 Adler M, Van Laethem J L, Franchimont D. et al . [Organized colorectal screening in French Community of Belgium and polyp surveillance].  Rev Med Brux. 2009;  30 253-260
    PubMedGoogle Scholar
  • 47 Vrangbaek K, Nielsen M. Colorectal cancer care in Denmark: status and dilemmas.  Eur J Health Econ. 2010;  10 5-13
    CrossrefPubMedGoogle Scholar
  • 48 Goulard H, Boussac-Zarebska M, Ancelle-Park R, Bloch J. French colorectal cancer screening pilot programme: results of the first round.  J Med Screen. 2008;  15 143-148
    CrossrefPubMedGoogle Scholar
  • 49 Goulard H, Boussac-Zarebska M, Ancelle-Park R, Bloch J. Évaluation épidémiologique du dépistage du cancer du côlon et du rectum. Premières campagnes du programme pilote français [Epidemiological evaluation of the French colorectal cancer screening pilot programme: results of the first round]. Saint-Maurice cedex Institut de veille sanitaire 2007 http://www.invs.sante.fr/publications/2007/cancer_colon_rectum/cancer_colon_rectum.pdf
    PubMedGoogle Scholar
  • 50 Ponchon T. Mass screening for colorectal cancer: the French program.  Endoscopy. 2007;  39 256
    Article in Thieme ConnectPubMedGoogle Scholar
  • 51 Chevreul K. Colorectal cancer in France.  Eur J Health Econ. 2010;  10 15-20
    CrossrefPubMedGoogle Scholar
  • 52 Pox C, Schmiegel W. Colorectal screening in Germany.  Z Gastroenterol. 2008;  46 31-32
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Dimitrakaki C A, Boulamatsis D B, Mariolis A C. et al . Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.  Eur J Cancer Prev. 2009;  18 248-257
    CrossrefPubMedGoogle Scholar
  • 54 Geitona M, Kanavos P. Colocteral cancer management and prevention policies in Greece.  Eur J Health Econ. 2010;  10 S27-S33
    CrossrefPubMedGoogle Scholar
  • 55 Masseria C. Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment.  Eur J Health Econ. 2010;  10 41-49
    CrossrefPubMedGoogle Scholar
  • 56 Zorzi M, Fedato C, Naldoni C. et al . Screening for colorectal cancer in Italy: 2007 survey.  Epidemiol Prev. 2009;  33 57-74
    PubMedGoogle Scholar
  • 57 Schurer W. The status of colorectal cancer care in the Netherlands: past, present and future.  Eur J Health Econ. 2010;  10 51-56
    CrossrefPubMedGoogle Scholar
  • 58 Lopez-Bastida J, Bellas-Beceiro B, Quintero-Carrión E. The challenge of colorectal cancer prevention in Spain.  Eur J Health Econ. 2010;  10 75-83
    CrossrefPubMedGoogle Scholar
  • 59 Hakama M, Hoff G, Kronborg O, Pahlman L. Screening for colorectal cancer.  Acta Oncologica. 2005;  44 425-439
    CrossrefPubMedGoogle Scholar
  • 60 Krebsliga Schweiz .Darmkrebs nie! Aber wie? Symposiumsbericht der Krebsliga Schweiz. 2007 Sept. 13. Bern; Krebsliga Schweiz 2008 Available at: http://www.colon-cancer.ch [Accessed: 25 Januar 2010]
    PubMedGoogle Scholar
  • 61 Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, IARC CancerBase No. 5. version 2.0. Lyon; IARC Press 2004
    PubMedGoogle Scholar
  • 62 Black R J, Bray F, Ferlay J, Parkin D M. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990.  Eur J Cancer. 1997;  33 1075-1107
    CrossrefPubMedGoogle Scholar
  • 63 Horner M J, Ries L AG, Krapcho M. et al .SEER Cancer Statistics Review, 1975 – 2006, National Cancer Institute. 2009 Bethesda, MD; http://seer.cancer.gov/csr/1975_2006 /, based on November 2008 SEER data submission, posted to the SEER web site
    PubMedGoogle Scholar
  • 64 Baier M, Calonge N, Cutter G. et al . Validity of self-reported colorectal cancer screening behavior.  Cancer Epidemiol Biomarkers Prev. 2000;  9 229-232
    PubMedGoogle Scholar
  • 65 Hall H I, Van Den Eeden S K, Tolsma D D. et al . Testing for prostate and colorectal cancer: comparison of self-report and medical record audit.  Prev Med. 2004;  39 27-35
    CrossrefPubMedGoogle Scholar

H. BrennerMD, MPH 

Division of Clinical Epidemiology and Aging Research
German Cancer Research Center (DKFZ)

Bergheimer Strasse 20
69115 Heidelberg
Germany

Fax: +49-6221-548141

Email: h.brenner@dkfz.de

      >